Carl Zeiss Meditec AG (ETR:AFX) has been given a €52.00 ($60.47) price target by research analysts at HSBC Holdings plc in a research report issued to clients and investors on Friday. The firm presently has a “buy” rating on the stock. HSBC Holdings plc’s price objective indicates a potential upside of 7.57% from the company’s current price.
Several other research firms also recently weighed in on AFX. DZ Bank AG reissued a “sell” rating on shares of Carl Zeiss Meditec AG in a research report on Thursday, October 19th. Berenberg Bank set a €48.00 ($55.81) price target on shares of Carl Zeiss Meditec AG and gave the company a “buy” rating in a report on Tuesday, October 17th. Independent Research GmbH set a €44.00 ($51.16) price target on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a report on Tuesday, August 15th. Commerzbank Ag set a €42.00 ($48.84) price target on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a report on Tuesday, August 8th. Finally, Deutsche Bank AG set a €40.00 ($46.51) price target on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. Carl Zeiss Meditec AG currently has a consensus rating of “Hold” and an average target price of €46.64 ($54.24).
Shares of Carl Zeiss Meditec AG (ETR AFX) opened at €48.34 ($56.21) on Friday. Carl Zeiss Meditec AG has a 1 year low of €30.80 ($35.81) and a 1 year high of €48.89 ($56.85).
TRADEMARK VIOLATION NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/12/carl-zeiss-meditec-ag-afx-pt-set-at-52-00-by-hsbc-holdings-plc.html.
Carl Zeiss Meditec AG Company Profile
Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.